You searched for "Breathing"

2935 results found

Carnoy’s and the KOT

This is a retrospective review of 105 patients with keratocystic odontogenic tumours treated over a 23-year period with a mean follow up of 86 months. The recurrence rate was 11.4%. Permanent neuro-sensory deficit of the inferior alveolar nerve 16%. Younger...

UCL Ear Institute / Royal National ENT Voice Course 2026

The two-day course will provide comprehensive coverage of voice pathology and treatment approaches.

Patient initiated follow-up in head and neck cancer

Is it time for a change in the way we follow up head and neck cancer patients after treatment? Paul Nankivell and Hisham Mehanna explain the rationale for the PETNECK2 trial. After completion of curative intent treatment, clinical follow-up currently...

From the editor Nov/Dec 2024

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk Never let it be said that we don’t provide a broad range of topics for you to digest. For...

From the editor JulAug19

Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net Welcome We are delighted to launch this current edition of ENT & Audiology News from Brussels,...

EUHA 2025: 69th International Congress of Hearing Aid Acousticians

EUHA 2025: 69th International Congress of Hearing Aid Acousticians will be held in Nuremberg, Germany, from 22 to 24 October 2025 We are building on last year's success and presenting our EUHA Live Area as a central meeting and networking area with special programme. It will be located in the Industry Exhibition. The event consists of a specialist conference featuring international lecturers and a trade fair with exhibitors from Germany and abroad. The EUHA Live Area connects the Congress and the Industry Exhibition even more closely. A central meeting and networking area with a stage will be created in the exhibition hall, where visitors can get information on the different topics.

Hubert Struycken and his monochord: when otologists still played the violin

It is almost impossible to imagine audiometry today without electronic tone generators, digital electronics or computers. At the beginning of the last century, however, the otologist relied on much simpler tools: a pocket watch, a tuning fork, or a Galton...

Management of infantile haemagiomas of the airway

This paper reviews the diagnosis and management of infantile haemagiomas (IH) affecting the airway. Approximately half of infants with this condition would also have cutaneous haemagiomas which are usually in the beard distribution. IH could affect any parts of the...

Sniffing out the evidence – COVID-19 and loss of sense of smell and taste

Louis Pasteur once observed: “In the fields of observation chance favors only the prepared mind.” Professor Hopkins was certainly prepared when a few anecdotes of smell problems started to accumulate early in the pandemic’s course. Post-viral olfactory loss is nothing...

How I lost my hearing aid…and other patient experiences

All audiologists, I am sure, would claim that they give full explanations of hearing aid controls and use of the devices at all fitting appointments. However, we know that patients do not always absorb all that they are told and...

Screening: evaluating the outcomes of early intervention

Newborn hearing screening is now the accepted standard of care in several countries, and is becoming increasingly more established worldwide. White [1] reported eight countries screening over 90% of newborns, ten screening between 25-89% of births and a further 54...

Should we reconsider induction chemotherapy in advanced stage laryngeal cancer?

Use of chemo-radiotherapy for advanced laryngeal cancer led to a major shift in treatment as an alternative to total laryngectomy. Despite widespread adoption of chemoradiotherapy, survival rates have not improved and the original premise of matching neoadjuvant chemotherapy tumour response...